Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
企業コードCYRX
会社名Cryoport Inc
上場日Jul 24, 2015
設立日1990
最高経営責任者「CEO」Mr. Jerrell Wilson (Jerry) Shelton
従業員数1090
証券種類Ordinary Share
決算期末Jul 24
本社所在地112 Westwood Place, Suite 350
都市BRENTWOOD
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号37027
電話番号19492321900
ウェブサイトhttps://www.cryoport.com/
企業コードCYRX
上場日Jul 24, 2015
設立日1990
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし